We have tracked over 176 funding programs and $85,622,342 allocated for Alzheimers Disease Research.
| Recent Funding Opportunity |
|---|
| National Institute on Aging Analysis of Alzheimers Disease Genome Sequencing Project Data U19 (apply for PAR 12 183) Funding Number: PAR 12 183 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Alzheimers Disease Research Centers (P50) (apply for RFA AG 10 002) Funding Number: RFA AG 10 002 Agency: National Institutes of Health Funding Amount: $1,000,000 |
| Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) (apply for PAR 25 374) Funding Number: PAR 25 374 Agency: National Institutes of Health Funding Amount: $1,000,000 |
| Development and Validation of Advanced Mammalian Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed) (apply for PAR 19 167) Funding Number: PAR 19 167 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01) (apply for RFA AG 17 056) Funding Number: RFA AG 17 056 Agency: Department of Health and Human Services, National Institutes of Health Funding Amount: $300,000 |
| Human Cell Reprogramming for Aging and Alzheimers Disease Research (R21) (apply for RFA AG 12 008) Funding Number: RFA AG 12 008 Agency: National Institutes of Health Funding Amount: $200,000 |
| High-Priority Behavioral and Social Research Networks in Alzheimers Disease and Alzheimers Disease-Related Dementias (R24 Clinical Trial Optional) (apply for RFA AG 22 012) Funding Number: RFA AG 22 012 Agency: National Institutes of Health Funding Amount: $250,000 |
| Deriving Common Data Elements from Real-World Data for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed) (apply for RFA AG 25 001) Funding Number: RFA AG 25 001 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Impact of Aging in Human Cell Models of Alzheimer's Disease (R01) (apply for RFA AG 17 009) Funding Number: RFA AG 17 009 Agency: HHS-NIH11 Funding Amount: $250,000 |
| FY11 Militarily Relevant Peer Reviewed Alzheimers Disease Research Program (MRPRA) Translational Research Award (apply for W81XWH 11 MRPRA TRA) Funding Number: W81XWH 11 MRPRA TRA Agency: Dept. of the Army USAMRAA Funding Amount: $500,000 |
| Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) (apply for RFA AG 18 021) Funding Number: RFA AG 18 021 Agency: National Institutes of Health Funding Amount: Case Dependent |
| New/Unconventional Animal Models of Alzheimers Disease (R24 Clinical Trial Not Allowed) (apply for RFA AG 21 003) Funding Number: RFA AG 21 003 Agency: Department of Health and Human Services, National Institutes of Health Funding Amount: Case Dependent |
| Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (apply for PAR 23 081) Funding Number: PAR 23 081 Agency: National Institutes of Health Funding Amount: Case Dependent |
| DOD FY13 Militarily Relevant Peer Reviewed Alzheimers Disease Quality of Life Research Award (apply for W81XWH 13 MRPRA QUAL) Funding Number: W81XWH 13 MRPRA QUAL Agency: Dept. of the Army USAMRAA Funding Amount: Case Dependent |
| Alzheimer's Disease Supportive Services Program (ADSSP): Creating and Sustaining Dementia-Capable Service Systems for People with Dementia and their Family Caregivers (apply for HHS 2017 ACL AOA ADSG 0212) Funding Number: HHS 2017 ACL AOA ADSG 0212 Agency: Department of Health and Human Services, Administration for Community Living Funding Amount: $650,000 |
| Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Required) (apply for RFA AG 23 034) Funding Number: RFA AG 23 034 Agency: National Institutes of Health Funding Amount: $500,000 |
| Grants for Alzheimers Disease Drug Discovery (R21) (apply for PAS 06 261) Funding Number: PAS 06 261 Agency: National Institutes of Health Funding Amount: $200,000 |
| Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) (apply for RFA AT 23 009) Funding Number: RFA AT 23 009 Agency: National Institutes of Health Funding Amount: $300,000 |
| Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) (apply for RFA AT 23 006) Funding Number: RFA AT 23 006 Agency: National Institutes of Health Funding Amount: $300,000 |
| Building Infrastructure for Precision Medicine Research on Minority Health and Disparities in Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (UH2/UH3 Clinical Trial Not Allowed) (apply for RFA AG 23 020) Funding Number: RFA AG 23 020 Agency: National Institutes of Health Funding Amount: $350,000 |
| Limited Competition Alzheimers Disease Neuroimaging Initiative, ADNI (U19) (apply for RFA AG 16 019) Funding Number: RFA AG 16 019 Agency: National Institutes of Health Funding Amount: $12,000,000 |
| Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01) (apply for PAR 17 038) Funding Number: PAR 17 038 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Exploratory Grant for NIA Alzheimers Disease Research Center (P20 Clinical Trial Not Allowed) (apply for RFA AG 20 023) Funding Number: RFA AG 20 023 Agency: National Institutes of Health Funding Amount: $750,000 |
| Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) (apply for PAR 22 048) Funding Number: PAR 22 048 Agency: National Institutes of Health Funding Amount: $500,000 |
| Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed) (apply for RFA AG 23 005) Funding Number: RFA AG 23 005 Agency: National Institutes of Health Funding Amount: Case Dependent |
Inside USGrants.org Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads